Legence shares are gaining as investors continue to price in the company’s latest fundamentals: record backlog and a higher 2026 outlook. On March 27, 2026, Legence reported year-end 2025 results highlighted by record quarterly revenue and disclosed that backlog and awarded contracts rose 49% to a record $3.7 billion, alongside raised full-year 2026 guidance for revenue of $3.7 billion to $3.9 billion and non-GAAP adjusted EBITDA of $400 million to $430 million. (globenewswire.com)

The market is treating backlog as a forward indicator for conversion into revenue across Legence’s end markets, with particular attention on data center-driven demand that helped power the recent quarter’s growth narrative. Analyst commentary has also been constructive: Stifel lifted its price target to $60 from $58 while maintaining a Buy rating on March 31, 2026, citing strength tied to the company’s positioning. (investing.com)

The next key checkpoint is the next earnings report (estimated for May 8, 2026, before market open), where investors will look for backlog conversion, margin/EBITDA progression versus the $400–$430 million full-year adjusted EBITDA guide, and any updates on demand in data centers and other mission-critical end markets. Separately, short-interest data points to meaningful positioning that can add volatility around catalysts. (stockanalysis.com)